EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Parkinson's Disease Patient‐Specific Striatum Organoids Show Hallmarks of Increased Inflammation

Kyriaki Barmpa, Claudia Saraiva, Alise Zagare, Mona Tuzza, Joseph Longworth, Elisa Zuccoli, Katrin Hufnagel, Florian Skwirblies, Ronny Schmidt, Dirk Brenner, Christoph Schröder, Jens C Schwamborn

Movement Disorders · 2026

DOI: 10.1002/mds.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Kyriaki Barmpa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg. Hauptthemen laut MEDLINE: Parkinson Disease, Corpus Striatum, Organoids, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds National de la Recherche Luxembourg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dopaminergic neurons from the substantia nigra pars compacta project their axons into the dorsal striatum, forming the nigrostriatal pathway. In Parkinson's disease (PD), dopaminergic terminals degenerate in the striatum, leading to dopamine depletion, which in turn causes alterations in the basal ganglia circuits that are essential for movement control. However, the reasons for dopaminergic neuron terminal degeneration in the striatum are still not understood. The LRRK2 gene is highly expressed in the striatum, and the LRRK2‐G2019S mutation is one of the most common mutations associated with PD. It is therefore tempting to speculate that dysregulations in the striatal functionality can initiate or contribute to the dopaminergic neuron terminals' degeneration.

Objectives

We aimed to examine the phenotypic differences between healthy and patient striatum organoids carrying the LRRK2‐G2019S mutation to assess whether specific alterations in the striatum that are independent of dopaminergic input could contribute to the development of the disease.

Methods

Striatum organoids were generated using healthy and PD patient–induced pluripotent stem cell lines, and they were cultured until day 80. We evaluated the levels of striatum‐specific proteins, and we performed proteomics and kinase activity analysis.

Results

PD striatum organoids revealed increased abundance of DRD2, DARPP32, and CDK5. Proteomics and kinase activity analysis demonstrated an inflammatory phenotype, which was further validated by investigating the occurrence of reactive astrocytes.

Conclusions

Striatum organoids recapitulate PD‐relevant phenotypes autonomously, independent of dopaminergic input. This includes a significant inflammatory phenotype. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseCorpus StriatumOrganoidsInflammationHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Dopaminergic NeuronsMutationMaleInduced Pluripotent Stem Cells

Stichwörter der Autor:innen

LRRK2‐G2019SParkinson's diseaseinflammationstriatum organoids

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, human

Autor:innen und Institutionen

  • Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Experimental and Molecular Immunology, Department of Infection and Immunity (DII), Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Immunology & Genetics, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Sciomics GmbH, Research & Development, Neckargemünd, Germany.
  • Odense Research Center for Anaphylaxis (ORCA), Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark.

Förderung

  • Fonds National de la Recherche Luxembourg

Zitieren

APA

Barmpa, K., Saraiva, C., Zagare, A., Tuzza, M., Longworth, J., Zuccoli, E., Hufnagel, K., Skwirblies, F., Schmidt, R., Brenner, D., Schröder, C., & Schwamborn, J. C. (2026). Parkinson's Disease Patient‐Specific Striatum Organoids Show Hallmarks of Increased Inflammation. Movement Disorders. https://doi.org/10.1002/mds.70176

Vancouver

Barmpa K, Saraiva C, Zagare A, Tuzza M, Longworth J, Zuccoli E, et al. Parkinson's Disease Patient‐Specific Striatum Organoids Show Hallmarks of Increased Inflammation. Movement Disorders. 2026. doi:10.1002/mds.70176

BibTeX
@article{Barmpa2026,
  author = {Barmpa, Kyriaki and Saraiva, Claudia and Zagare, Alise and Tuzza, Mona and Longworth, Joseph and Zuccoli, Elisa and Hufnagel, Katrin and Skwirblies, Florian and Schmidt, Ronny and Brenner, Dirk and Schröder, Christoph and Schwamborn, Jens C},
  title = {Parkinson's Disease Patient‐Specific Striatum Organoids Show Hallmarks of Increased Inflammation},
  journal = {Movement Disorders},
  year = {2026},
  doi = {10.1002/mds.70176}
}
Kostenlos starten →